首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Evaluation of efficacy and tolerability of eperisone and thiocolchicoside in treatment of low back pain associated with muscle spasm: An open label, prospective, randomized controlled trial
【24h】

Evaluation of efficacy and tolerability of eperisone and thiocolchicoside in treatment of low back pain associated with muscle spasm: An open label, prospective, randomized controlled trial

机译:依匹乐松和硫代秋水仙苷治疗与肌肉痉挛相关的下腰痛的疗效和耐受性评估:一项开放性,前瞻性,随机对照试验

获取原文
           

摘要

Background: Low back pain has a high prevalence in adult population. Because of reflex muscle spasm, muscle relaxants are frequently used either alone or in combination with analgesics. Eperisone inhibits voltage gated sodium channels in brain stem and Thiocolchicoside acts via GABA-mediated mechanism to relax muscle spasm and relieves pain. Methods: This was a prospective; open labeled, randomized, two-arm, parallel group, controlled, clinical trial. 113 patients were randomised to two groups. Patients in group A received Tablet Eperisone 100 mg whereas patients in group B received Tablet Thiocolchicoside 8 mg for seven days along with Tablet Paracetamol 500 mg. The outcome measures of trial were the improvement in finger to floor distance (FFD) and pain in lumbar region, relief of spasm and tenderness of paravertebral muscles on day 4 and 7. Results: At the end of the study FFD reduced by 18 cm in group A (p < 0.0001*) and 17.36 cm in group B (p.
机译:背景:腰痛在成人人群中普遍存在。由于反射性肌肉痉挛,肌肉松弛剂经常单独使用或与止痛药联合使用。 Eperisone抑制脑干中的电压门控钠通道,而硫秋水仙苷则通过GABA介导的机制起作用,以缓解肌肉痉挛并缓解疼痛。方法:这是一个前瞻性研究;开放标签,随机,两臂,平行组,对照,临床试验。 113例患者被随机分为两组。 A组患者接受100毫克片剂Eperisone,而B组患者接受500毫克硫柳糖苷8毫克片剂和500毫克扑热息痛片剂。试验的结果指标是指到地板距离(FFD)和腰部疼痛改善,痉挛缓解和椎旁肌压痛在第4天和第7天有所改善。结果:研究结束时,FFD降低了18 cm。 A组(p <0.0001 *)和B组17.36 cm(p。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号